Company / Share Buybacks
AbbVie Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$980.0M
FY2025
5-year range
$934.0M / $2.0B
FY2021-FY2025
Trend
-42.6%
vs FY2024
Sector context
#10 of 48
Health Care
What the data says
AbbVie's share buybacks of $980M is higher than 79% of companies in the Health Care sector (FY2025). Share Buybacks has fluctuated over the past 10 years, ranging from $629M in FY2019 to $12.0B in FY2018.
Based on SEC 10-K filings.
$980M in FY2025 with a 5-year CAGR of +0.0%. Top quartile in the Health Care sector.
Declined from $2.0B to $980M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -13.0%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 48This company $980.0M Sector average $638.3M
▼
+53.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.0%, indicating consistent growth.
- In FY2025, share buybacks decreased 42.6% year-over-year.
- Ranks #10 out of 48 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $980.0M | -42.6% |
| FY2024 | $1.7B | -13.4% |
| FY2023 | $2.0B | +32.6% |
| FY2022 | $1.5B | +59.2% |
| FY2021 | $934.0M | -4.5% |
| FY2020 | $978.0M | +55.5% |
| FY2019 | $629.0M | -94.8% |
| FY2018 | $12.0B | +752.1% |
| FY2017 | $1.4B | -76.6% |
| FY2016 | $6.0B | -20.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026